Showing results (31-40 of 74) with videos related to

Sort By:
Pageof 8
European Journal of Pharmacology|December 6, 2022
Anti-pancreatic lipase and anti-adipogenic effects of 5, 7, 3',4',5' -pentamethoxy and 6, 2',4'-trimethoxy flavone - An In vitro studyBilal Ahmad, Emily P Friar, Emerald Taylor, et al.
Chemico-Biological Interactions|April 21, 2023
Hydroxylated polymethoxyflavones reduce the activity of pancreatic lipase, inhibit adipogenesis and enhance lipolysis in 3T3-L1 mouse embryonic fibroblast cellsBilal Ahmad, Emily P Friar, Muhammad Sufyan Vohra, et al.
Journal of Medicinal Chemistry|April 25, 2007
Rapid evolution of 6-phenylpurine inhibitors of protein kinase B through structure-based designAlastair Donald, Tatiana McHardy, Martin G Rowlands, et al.
Metabolomics : Official Journal of the Metabolomic Society|April 15, 2020
Metabolomic changes of the multi (-AGC-) kinase inhibitor AT13148 in cells, mice and patients are associated with NOS regulationAkos Pal, Yasmin Asad, Ruth Ruddle, et al.
Journal of Medicinal Chemistry|April 25, 2007
Identification of inhibitors of protein kinase B using fragment-based lead discoveryGordon Saxty, Steven J Woodhead, Valerio Berdini, et al.
Cancer Research|January 18, 2011
CCT241533 is a potent and selective inhibitor of CHK2 that potentiates the cytotoxicity of PARP inhibitorsVictoria E Anderson, Michael I Walton, Paul D Eve, et al.
Drug Discovery Today|December 8, 2009
Can molecular biomarker-based patient selection in Phase I trials accelerate anticancer drug development?Craig P Carden, Debashis Sarker, Sophie Postel-Vinay, et al.
Journal of Molecular Biology|February 6, 2007
A structural comparison of inhibitor binding to PKB, PKA and PKA-PKB chimeraThomas G Davies, Marcel L Verdonk, Brent Graham, et al.
International Journal of Radiation Oncology, Biology, Physics|September 18, 2012
Targeted radiosensitization by the Chk1 inhibitor SAR-020106Gerben R Borst, Martin McLaughlin, Joan N Kyula, et al.
Assay and Drug Development Technologies|July 20, 2007
Application of meso scale technology for the measurement of phosphoproteins in human tumor xenograftsSharon M Gowan, Anthea Hardcastle, Albert E Hallsworth, et al.
Pageof 8